Signal

BEHAVIORAL2 trials

Sponsors

UMC Utrecht, Dana-Farber Cancer Institute

Conditions

Cervical CancerDiabetes MellitusFallopian Tube CancerGynecologic CancerOvarian CancerPrimary Peritoneal CarcinomaUterine Cancer

Unknown Phase

Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes Patients

CompletedNCT02229110

UMC UtrechtDiabetes Mellitus

Start: 2013-10-31End: 2015-03-31Updated: 2015-06-16

SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care

WithdrawnNCT04368130

Dana-Farber Cancer InstituteCervical Cancer, Fallopian Tube Cancer, Gynecologic Cancer +3

Start: 2022-09-01End: 2023-09-01Updated: 2022-10-14